17070 Red Oak dr Ste 103 — Houston, Texas

17070 Red Oak dr Ste 103 is a clinical research site located in Houston, Texas, United States 77090.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

17070 Red Oak dr Ste 103 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus With Diabetic Nephropathy.

Sponsors: Calliditas Therapeutics AB.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 17070 Red Oak dr Ste 103?

17070 Red Oak dr Ste 103 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 17070 Red Oak dr Ste 103 conducted?

17070 Red Oak dr Ste 103 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus With Diabetic Nephropathy.

Is 17070 Red Oak dr Ste 103 accredited by Crixeo Health?

17070 Red Oak dr Ste 103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 17070 Red Oak dr Ste 103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.